Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hypermethylation-associated downregulation of microRNA-4456 in hypersexual disorder with putative influence on oxytocin signalling: A DNA methylation analysis of miRNA genes.
Boström AE, Chatzittofis A, Ciuculete DM, Flanagan JN, Krattinger R, Bandstein M, Mwinyi J, Kullak-Ublick GA, Öberg KG, Arver S, Schiöth HB, Jokinen J. Boström AE, et al. Among authors: chatzittofis a. Epigenetics. 2020 Jan-Feb;15(1-2):145-160. doi: 10.1080/15592294.2019.1656157. Epub 2019 Sep 22. Epigenetics. 2020. PMID: 31542994 Free PMC article.
Low CSF oxytocin reflects high intent in suicide attempters.
Jokinen J, Chatzittofis A, Hellström C, Nordström P, Uvnäs-Moberg K, Asberg M. Jokinen J, et al. Among authors: chatzittofis a. Psychoneuroendocrinology. 2012 Apr;37(4):482-90. doi: 10.1016/j.psyneuen.2011.07.016. Epub 2011 Aug 17. Psychoneuroendocrinology. 2012. PMID: 21852050
CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters.
Chatzittofis A, Nordström P, Hellström C, Arver S, Åsberg M, Jokinen J. Chatzittofis A, et al. Eur Neuropsychopharmacol. 2013 Oct;23(10):1280-7. doi: 10.1016/j.euroneuro.2013.02.002. Epub 2013 Feb 28. Eur Neuropsychopharmacol. 2013. PMID: 23453639
HPA axis dysregulation in men with hypersexual disorder.
Chatzittofis A, Arver S, Öberg K, Hallberg J, Nordström P, Jokinen J. Chatzittofis A, et al. Psychoneuroendocrinology. 2016 Jan;63:247-53. doi: 10.1016/j.psyneuen.2015.10.002. Epub 2015 Oct 28. Psychoneuroendocrinology. 2016. PMID: 26519779 Clinical Trial.
CSF and plasma testosterone in attempted suicide.
Stefansson J, Chatzittofis A, Nordström P, Arver S, Åsberg M, Jokinen J. Stefansson J, et al. Among authors: chatzittofis a. Psychoneuroendocrinology. 2016 Dec;74:1-6. doi: 10.1016/j.psyneuen.2016.08.009. Epub 2016 Aug 20. Psychoneuroendocrinology. 2016. PMID: 27567115
Methylation of HPA axis related genes in men with hypersexual disorder.
Jokinen J, Boström AE, Chatzittofis A, Ciuculete DM, Öberg KG, Flanagan JN, Arver S, Schiöth HB. Jokinen J, et al. Among authors: chatzittofis a. Psychoneuroendocrinology. 2017 Jun;80:67-73. doi: 10.1016/j.psyneuen.2017.03.007. Epub 2017 Mar 10. Psychoneuroendocrinology. 2017. PMID: 28319850
Normal Testosterone but Higher Luteinizing Hormone Plasma Levels in Men With Hypersexual Disorder.
Chatzittofis A, Boström AE, Öberg KG, Flanagan JN, Schiöth HB, Arver S, Jokinen J. Chatzittofis A, et al. Sex Med. 2020 Jun;8(2):243-250. doi: 10.1016/j.esxm.2020.02.005. Epub 2020 Mar 12. Sex Med. 2020. PMID: 32173350 Free PMC article.
MAIN OUTCOME MEASURES: Testosterone and LH plasma levels in association with clinical rating and a secondary outcome was the epigenetic profile of HPA and HPG axis-coupled CpG sites with testosterone and LH levels. ...CONCLUSIONS: Subtle dysregulation of the HPG axis, with …
MAIN OUTCOME MEASURES: Testosterone and LH plasma levels in association with clinical rating and a secondary outcome was the epigenet …
Naltrexone in Compulsive Sexual Behavior Disorder: A Feasibility Study of Twenty Men.
Savard J, Öberg KG, Chatzittofis A, Dhejne C, Arver S, Jokinen J. Savard J, et al. Among authors: chatzittofis a. J Sex Med. 2020 Aug;17(8):1544-1552. doi: 10.1016/j.jsxm.2020.04.318. Epub 2020 Jun 10. J Sex Med. 2020. PMID: 32532705
CONCLUSION: Naltrexone is feasible and tolerable and may reduce symptoms of CSBD; nevertheless, future studies should ensure a randomized controlled procedure to evaluate possible effectiveness. Savard J, Oberg KG, Chatzittofis A, et al. Naltrexone in Compuls …
CONCLUSION: Naltrexone is feasible and tolerable and may reduce symptoms of CSBD; nevertheless, future studies should ensure a random …
43 results